Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Import of Veterinary Drugs and Feed Supplements to Russia (May 2020)

Monday, July 6, 2020

Between January and May 2020, Russia imported 11.3 bln RUB worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 2.3% lower than in 2019, and 16.9 bln RUB worth of feed supplements, with the dynamics of +12.9% in monetary terms.

The import dynamics varied according to animal type: +4.2% for veterinary drugs for livestock and -21% for pets, +28% for feed supplements for livestock and +12% for pets.

While the dynamics of the import of veterinary drugs in monetary terms were only +5.6% and 3.1% in March and April 2020, respectively, the dynamics skyrocketed to +27.8% in May 2020. Following April's trend, the dynamics of the import of feed supplements in May were +18.3%.

The dynamics in physical terms between January and May 2020 mostly copied those in monetary terms: -14.4% for the import of veterinary drugs and +8.4% for feed supplements. However, in May 2020 the dynamics were +23.8% and -15.6% for veterinary drugs and feed supplements, respectively.

The number of manufacturers importing veterinary drugs to Russia has grown from 99 to 103. Companies out of the top 20 were the ones that had the best import dynamics between January and May 2020. In particular, Gigi (Latvia) had the highest dynamics in monetary terms (imports grown by 9.2 times). Among the two veterinary drugs that the company imported, drug for congestive heart failure in dogs PimoPet contributed to the dynamics the most. Gigi is followed by Ashish Life Science (India), the company's imports has increased by 5.1 times. Ashish Life Science is familiar to Russian consumers as the manufacturer of drugs for livestock treatment. Its insectoacaricide Diazecto contributed to the dynamics the most.

As for feed supplements, Mixscience (France) has the highest dynamics (imports grown by nearly 32 times). The company imported only one product – Valopro, supplement for ruminant animals, which helps to improve the absorption of protein and energy.

Dynamics of import of veterinary drugs and feed supplements to Russia (EEU countries excluded), free circulation prices including customs clearance and VAT (2016 – 2019, January – May 2020)